Skip to content
LexBuild

Center for Scientific Review; Notice of Closed Meetings

---
identifier: "/us/fr/2025-12382"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Center for Scientific Review; Notice of Closed Meetings"
title_number: 0
title_name: "Federal Register"
section_number: "2025-12382"
section_name: "Center for Scientific Review; Notice of Closed Meetings"
positive_law: false
currency: "2025-07-02"
last_updated: "2025-07-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2025-12382"
document_type: "notice"
publication_date: "2025-07-02"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "90 FR 29030"
fr_volume: 90
---

#  Center for Scientific Review; Notice of Closed Meetings

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Neurodevelopment and Disorders.

*Date:* August 5-6, 2025.

*Time:* 9:00 a.m. to 7:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Chi-Tso Chiu, Ph.D., Scientific Review Officer, Scientific Review Branch (SRB), Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, DHHS, 6710B Rockledge Drive, Rm. 2127B, Bethesda, MD 20817, (301) 435-7486, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Clinical Trial: Topics in Immunology, Viral, Bacterial, and Parasitic Disease.

*Date:* August 5, 2025.

*Time:* 10:00 a.m. to 6:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Robert C. Unfer, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3F40A, National Institutes of Health, NIAID, 5601 Fishers Lane, MSC 9834, Bethesda, MD 20892-9834, (240) 669-5035, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; RFA Panel: BRAIN development and validation of novel tools for cell-specific and circuit-specific processes.

*Date:* August 5, 2025.

*Time:* 10:00 a.m. to 4:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Victor Henriquez, Ph.D., Scientific Review Officer, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 6701 Democracy Blvd., Democracy 1, Room 1066, Bethesda, MD 20892-4878, (301) 435-0813, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Research Career Development Awards SEP B.

*Date:* August 6, 2025.

*Time:* 9:00 a.m. to 6:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Rebecca Steiner Garcia, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6149, MSC 9606, Bethesda, MD 20892-9606, 301-443-4525, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Biomedical Imaging Approaches in Cancer Research.

*Date:* August 6, 2025.

*Time:* 9:00 a.m. to 6:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Vera A Cherkasova, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6710B Rockledge Drive, Room 2137B, Bethesda, MD 20892, (240) 731-6040, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Cellular and Molecular Aspects of the Blood-Brain Barrier and Neurovascular System and Therapeutic Strategies.

*Date:* August 7, 2025.

*Time:* 9:00 a.m. to 5:30 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Eric S. Tucker, Ph.D., Scientific Review Officer, Scientific Review Branch, Neuroscience Center, 6001 Executive Blvd., Rockville, MD 20852, (301) 827-0799, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in HIV Comorbidities, Coinfections and Associated Cancers.

*Date:* August 7, 2025.

*Time:* 10:00 a.m. to 5:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Caitlin Elizabeth Angela Moyer, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 443-4577, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; RFA: Clinical Care and Interventions for Substance Use Disorders, Prevention, and Treatment of Addiction.

*Date:* August 11-12, 2025.

*Time:* 9:30 a.m. to 5:30 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Marisa Srivareerat, Ph.D., Scientific Review Officer, Scientific Review Branch, Office of Extramural Policy, National Institute on Drug Abuse, NIH, 11601 Landsdown Street, 3WF Room 09C49, Bethesda, MD 20892, (301) 435-1258, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; PAR-23-124: Genomic Community Resources (U24).

*Date:* August 11, 2025.

*Time:* 10:00 a.m. to 4:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Maryam Rohani, Ph.D., Scientific Review Officer, NIAID Immunology Review Branch, BG 5601 Fishers Lane, Rm. 3G56, Rockville, MD 20852, (301) 761-6656, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Program Projects: NIA Program Project Applications (P01) Review.

*Date:* August 12, 2025.

*Time:* 9:00 a.m. to 12:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Eric S. Tucker, Ph.D., Scientific Review Officer, Scientific Review Branch, Neuroscience Center, 6001 Executive Blvd., Rockville, MD 20852, (301) 827-0799, *[email protected]* .

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: June 30, 2025.

Bruce A. George,

Program Analyst, Office of Federal Advisory Committee Policy.